SIR-SPHERES

FDA Premarket Approval P990065 S004

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a manufacturing and sterilization site located in wilmington, massachusetts.

DeviceSIR-SPHERES
Generic NameMicrospheres Radionuclide
ApplicantSirtex Medical Pty Ltd
Date Received2006-05-15
Decision Date2008-01-18
PMAP990065
SupplementS004
Product CodeNAW 
Advisory CommitteeRadiology
Supplement TypeNormal 180 Day Track No User Fee
Supplement ReasonExpress Gmp Supplement
Expedited ReviewNo
Combination Product No
Applicant Address Sirtex Medical Pty Ltd shop 6 207 Pacific Highway st Leonards, New South Wales 2065

Supplemental Filings

Supplement NumberDateSupplement Type
P990065Original Filing
S012 2022-03-21 30-day Notice
S011
S010 2016-12-19 Special (immediate Track)
S009 2016-08-08 Normal 180 Day Track No User Fee
S008 2015-01-15 30-day Notice
S007 2014-09-09 Special (immediate Track)
S006 2011-09-19 Normal 180 Day Track No User Fee
S005
S004 2006-05-15 Normal 180 Day Track No User Fee
S003
S002
S001 2003-03-25 Special (immediate Track)

NIH GUDID Devices

Device IDPMASupp
M425SIRY0010 P990065 006
00850014612146 P990065 015

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.